Gene · 6358
CCL14: C-C motif chemokine ligand 14
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. CCL14: C-C motif chemokine ligand 14. Genes, record 6358. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/6358
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q16627 | C-C motif chemokine 14 | 93 | 2 | Ensembl, GeneID, HGNC |
Source UniProt
Patents692
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026120675 A | 2026-07-22 | 730 | Q16627 | Espacenet |
| US 12655205 B2 | 2026-06-16 | 21 | Q16627 | Espacenet |
| EP 4705273 A2 | 2026-03-11 | 343 | Q16627 | Espacenet |
| EP 4705273 A2 | 2026-03-11 | 361 | Q16627 | Espacenet |
| EP 4705273 A2 | 2026-03-11 | 408 | Q16627 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 40996 | Q16627 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 18567 | Q16627 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 2126 | Q16627 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 16624 | Q16627 | Espacenet |
| EP 4606428 A2 | 2025-08-27 | 41 | Q16627 | Espacenet |
1 to 10 of 692
See all 692 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,893
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | CCL14 papers | Newest fiscal year |
|---|---|---|---|
| P30CA008748 | Cancer Center Support Grant | 13 | 2025 |
| P30CA068485 | Cancer Center Support Grant | 7 | 2025 |
| UL1TR001863 | Yale Clinical and Translational Science Award | 7 | 2025 |
| P30CA046934 | University of Colorado Cancer Center Support Grant | 6 | 2025 |
| P30CA015083 | Mayo Clinic Comprehensive Cancer Center Support Grant | 5 | 2025 |
| P30CA023074 | University of Arizona Cancer Center - Cancer Center Support Grant | 5 | 2025 |
| P30CA124435 | Stanford Cancer Institute | 5 | 2025 |
| P30CA015704 | Cancer Center Support Grant | 4 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 4 | 2025 |
| P30CA033572 | Cancer Center Support Grant | 4 | 2025 |
1 to 10 of 1,893Source NIH's project files
See all 1,893 nih grantsPapers2,754
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Macrophage-CD8+ T Cell Spatial Coupling Defines an Innate-Adaptive Injury Niche in Human Checkpoint Inhibitor Hepatotoxicity. | medRxiv | 2026 | 42818881 | PubTator, text mining | PubMed |
| Beyond creatinine: biomarkers of kidney recovery after acute kidney injury. | Curr Opin Nephrol Hypertens | 2026 | 42817189 | PubTator, text mining | PubMed |
| Validation of Urinary C-C Motif Chemokine Ligand 14 for Persistent Severe Acute Kidney Injury Using Clinical Adjudication. | Clin J Am Soc Nephrol | 2026 | 42747895 | PubTator, text mining | PubMed |
| Structural rearrangements underlying the activation of STIM1 by ER calcium depletion. | Proc Natl Acad Sci U S A | 2026 | 42612005 | PubTator, text mining | PubMed |
| Integrated Transcriptomic Analysis of NOTCH1- and MYB-Associated Immune Features in SACC. | Int J Mol Sci | 2026 | 42511840 | PubTator, text mining | PubMed |
| Biodistribution of tumor-targeted MXene-antibody conjugates. | Biomater Sci | 2026 | 42458933 | PubTator, text mining | PubMed |
| Perithyroidal Adipose Tissue Drives Thyroid Tumorigenesis through Adipokine Signaling and Immune Suppression. | Research (Wash D C) | 2026 | 42453940 | PubTator, text mining | PubMed |
| Deciphering Angiogenic Drivers in Hepatocellular Carcinoma: From Prognostic Signature Construction to Genistein-Mediated Inhibition. | J Cell Mol Med | 2026 | 42178613 | PubTator, text mining | PubMed |
| Molecular Biomarkers and Risk Prediction Models for Acute Kidney Injury Following Liver Transplantation: A Review. | J Clin Exp Hepatol | 2026 | 42165038 | PubTator, text mining | PubMed |
| An integrated single-cell and spatial proteotranscriptomics atlas of fibroblast-driven immunoregulation within the human adult oral cavity. | Cell Press Blue | 2026 | 42147490 | PubTator, text mining | PubMed |
1 to 10 of 2,754
See all 2,754 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/6358
GET https://conductscience.org/api/genes/v1/6358/patents?page=2